Legal Performance-Enhancing Substances, Later Use of Anabolic-Androgenic Steroids in Young Adults

JAMA Pediatrics

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, MAY 18, 2020

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2020.0883?guestAccessKey=3229868d-5a1e-4cf9-90d4-8b0c442dc04b&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=051820

 

What The Study Did: Whether using legal performance-enhancing substances was associated with subsequent use of anabolic-androgenic steroids was the focus of this study that included nearly 13,000 individuals surveyed at ages 18 to 26 about the use of these substances and then surveyed again seven years later.

Authors: Jason M. Nagata, M.D., M.Sc., of the University of California, San Francisco, is the corresponding author.

 

(doi:10.1001/jamapediatrics.2020.0883)

Editor’s Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.